Express Scripts Sues to Block Closure of Major Memphis Specialty Pharmacy
CI sits 24% above its 52-week low of $239.51 on light trading volume (0.4× avg).
Summary
Cigna's Evernorth subsidiary, Express Scripts, has filed a lawsuit to prevent the closure of a major specialty pharmacy in Memphis. The suit challenges a state law that Express Scripts claims would reduce access to prescription medications for Tennesseans. This legal action highlights a potential operational disruption and regulatory challenge for Cigna's pharmacy benefit management segment. The outcome of the lawsuit will determine the future of the Memphis facility and could impact Cigna's ability to serve customers in the region.
At the time of this announcement, CI was trading at $297.38 on NYSE in the Life Sciences sector, with a market capitalization of approximately $78.7B. The 52-week trading range was $239.51 to $338.89. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.